Taxanes Hybrid Nanovectors: From Design to Physico‐Chemical Evaluation of Docetaxel and Paclitaxel Gold (III)‐PEGylated Complex Nanocarriers

[1]  M. Hormozi-Nezhad,et al.  A new bifunctional hybrid nanostructure as an active platform for photothermal therapy and MR imaging , 2016, Scientific Reports.

[2]  A. Paillard,et al.  SERS spectroscopic approach to study doxorubicin complexes with Fe(2+) ions and drug release from SPION-based nanocarriers. , 2013, The Analyst.

[3]  G. Tortora,et al.  EGFR antagonists in cancer treatment. , 2008, The New England journal of medicine.

[4]  Jolanda Spadavecchia,et al.  One-step synthesis of collagen hybrid gold nanoparticles and formation on Egyptian-like gold-plated archaeological ivory. , 2014, Angewandte Chemie.

[5]  Nathalie Dupont,et al.  Tunable Design of Gold(III)-Doxorubicin Complex-PEGylated Nanocarrier. The Golden Doxorubicin for Oncological Applications. , 2016, ACS applied materials & interfaces.

[6]  D. Gerber.  EGFR inhibition in the treatment of non‐small cell lung cancer , 2008, Drug development research.

[7]  Priyabrata Mukherjee,et al.  Gold nanoparticles: opportunities and challenges in nanomedicine , 2010, Expert opinion on drug delivery.

[8]  D. Hirst,et al.  Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.

[9]  G. Zhai,et al.  Current development in nanoformulations of docetaxel , 2012, Expert opinion on drug delivery.

[10]  H. Wang,et al.  Experimental antitumor activity of the Ce(IV)-mitoxantrone complex and its interaction with deoxyribonucleic acid. , 1997, Journal of inorganic biochemistry.

[11]  Adriele Prina-Mello,et al.  Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies , 2016, International journal of nanomedicine.

[12]  Polyethylene glycol gold-nanoparticles: Facile nanostructuration of doxorubicin and its complex with DNA molecules for SERS detection , 2016 .

[13]  E. Kang,et al.  Paclitaxel distribution in poly(ethylene glycol)/poly(lactide-co-glycolic acid) blends and its release visualized by coherent anti-Stokes Raman scattering microscopy. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[14]  J. Spadavecchia,et al.  One-pot synthesis of a gold nanoparticle–Vmh2 hydrophobin nanobiocomplex for glucose monitoring , 2016, Nanotechnology.

[15]  B. Chan,et al.  Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. , 2015, Translational lung cancer research.

[16]  U. Holzgrabe,et al.  Vibrational spectroscopic characterization of fluoroquinolones. , 2005, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[17]  L. Rivory,et al.  Clinical Pharmacokinetics of Docetaxel , 1999, Clinical pharmacokinetics.

[18]  I. Correia,et al.  Design of oligoaziridine-PEG coatings for efficient nanogold cellular biotagging , 2015 .

[19]  S Garattini,et al.  Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures , 2005, British Journal of Cancer.

[20]  Kinam Park,et al.  In situ visualization of paclitaxel distribution and release by coherent anti-Stokes Raman scattering microscopy. , 2006, Analytical chemistry.

[21]  J. Schellens,et al.  Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes , 2001, Investigational New Drugs.

[22]  W. Hou,et al.  Facile synthesis of concentrated gold nanoparticles with low size-distribution in water: temperature and pH controls , 2011, Nanoscale research letters.

[23]  Richard M Crooks,et al.  Extraction of Au nanoparticles having narrow size distributions from within dendrimer templates. , 2004, Journal of the American Chemical Society.

[24]  A. Ghosh,et al.  Biosynthesis and characterization of gold nanoparticles: Kinetics, in vitro and in vivo study. , 2017, Materials science & engineering. C, Materials for biological applications.

[25]  D. Astruc,et al.  Encapsulation of Docetaxel into PEGylated Gold Nanoparticles for Vectorization to Cancer Cells , 2011, ChemMedChem.

[26]  Srikanth Pilla,et al.  Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. , 2009, Biomaterials.

[27]  Yongchun Liu,et al.  High drug-loading nanomedicines: progress, current status, and prospects , 2017, International journal of nanomedicine.

[28]  John Mendelsohn,et al.  The EGF receptor family as targets for cancer therapy , 2000, Oncogene.

[29]  S. Carabineiro,et al.  Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines † , 2017, Molecules.

[30]  G. Hortobagyi,et al.  Docetaxel for treatment of solid tumours: a systematic review of clinical data. , 2005, The Lancet. Oncology.

[31]  M. El-Sayed,et al.  Spectral Properties and Relaxation Dynamics of Surface Plasmon Electronic Oscillations in Gold and Silver Nanodots and Nanorods , 1999 .

[32]  Shengchun Yang,et al.  UV irradiation induced formation of Au nanoparticles at room temperature: The case of pH values , 2007 .

[33]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[34]  N. Zhang,et al.  How nanotechnology can enhance docetaxel therapy , 2013, International journal of nanomedicine.

[35]  Ali Akbar Pourfatollah,et al.  Various methods of gold nanoparticles (GNPs) conjugation to antibodies , 2016 .

[36]  J. Skepper,et al.  The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages☆ , 2014, Biomaterials.

[37]  Shiladitya Sengupta,et al.  Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy , 2010, Proceedings of the National Academy of Sciences.

[38]  N. Normanno,et al.  Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. , 2003, Endocrine-related cancer.

[39]  M. Miller,et al.  Chemistry and chemical biology of taxane anticancer agents. , 2001, The chemical record.

[40]  E. Zubarev,et al.  Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.

[41]  M. Prabaharan,et al.  Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. , 2009, Biomaterials.

[42]  Chang‐jun Liu.  Size-Controlled Synthesis of Colloidal Gold Nanoparticles at Room Temperature Under the Influence of Glow Discharge , 2009, Nanoscale research letters.

[43]  H. Loh,et al.  Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment , 2016, Scientific Reports.

[44]  S. Libutti,et al.  Colloidal gold: a novel nanoparticle for targeted cancer therapeutics. , 2010, Methods in molecular biology.

[45]  I. Capek.  Dispersions of polymer ionomers: I. , 2004, Advances in colloid and interface science.

[46]  S. Cheng,et al.  Gold-doxorubicin nanoconjugates for overcoming multidrug resistance. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[47]  D. Kingston,et al.  Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. , 2016, Bioconjugate chemistry.

[48]  M. Urban,et al.  Phospholipid-stabilized Au-nanoparticles. , 2005, Biomacromolecules.

[49]  Andrzej S Pitek,et al.  Tuning of nanoparticle biological functionality through controlled surface chemistry and characterisation at the bioconjugated nanoparticle surface , 2015, Scientific Reports.